Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.

Journal of the National Cancer Institute. Monographs

Volumn , Issue 28, 2001, Pages 44-49

  Cattelan, A M ^a   Calabro M L ^a   Gasperini, P ^a   Aversa, S M ^a   Zanchetta, M ^a   Meneghetti, F ^a   De Rossi, A ^a   Chieco Bianchi, L ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS ANTIBODY; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; DRUG SCREENING; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; ISOLATION AND PURIFICATION; KAPOSI SARCOMA; MALE; MIDDLE AGED; MUCOSA; PATHOLOGY; PROSPECTIVE STUDY; REMISSION; SKIN TUMOR; SOFT TISSUE TUMOR; TREATMENT OUTCOME; VIREMIA; VIROLOGY; VIRUS LOAD; VISCERA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; ANTIBODIES, VIRAL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; DRUG EVALUATION; FOLLOW-UP STUDIES; HERPESVIRUS 8, HUMAN; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PROSPECTIVE STUDIES; REMISSION INDUCTION; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; SARCOMA, KAPOSI; SKIN NEOPLASMS; SOFT TISSUE NEOPLASMS; TREATMENT OUTCOME; VIRAL LOAD; VIREMIA; VISCERA;

EID: 1842638271     PISSN: 10526773     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)